Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Zijin buys 9.2% stake in Allied Gold via C$417 million placement
Allied Gold raised C$416.64 million from Zijin Gold via a private placement, giving the Chinese miner a 9.2% stake. The funds will support e
M&A Monday: Jazz's $1.32B Actio Deal, Verisk Forced to Close $2.35B AccuLynx
Monday brought a flurry of dealmaking across pharma, energy, and sports. Jazz Pharmaceuticals agreed to pay up to $1.32 billion for Actio, w
Blackstone's Safe Harbor to buy MarineMax for $1.5 billion cash deal
Blackstone's Safe Harbor will acquire MarineMax for $53 per share in cash, valuing the boat retailer at about $1.5 billion including debt. S
PNE's sale hits snag as buyers balk at €757.6m price tag
PNE's sale process is struggling as potential buyers are unwilling to pay the company's €757.61 million market value. The German renewables
Silence, MarineMax, Varex surge on big news: deals and trial data
Three small- and mid-cap stocks surged Monday: Silence Therapeutics on positive phase 2 data, MarineMax and Varex on billion-dollar buyouts.
UBS Raises Brinker Target to $260 on Chili's Momentum
UBS raised its price target on Brinker International to $260 from $190, citing sustained momentum at Chili's. The bank expects same-store sa
Eli Lilly's UK approval lifts healthcare stocks, but Sionna's trial setback weighs
Healthcare stocks gained Monday after Eli Lilly secured UK approval for its once-daily weight-loss pill Foundayo. But Sionna Therapeutics tu
UBS cuts Chemours to neutral, slashes price target to $18 on refrigerant slowdown
UBS downgraded Chemours to neutral and cut its price target to $18 from $29, warning that refrigerant demand is cooling as distributors work
Nutrien's potash automation and buybacks sharpen its cost edge
Nutrien is using automation to keep potash costs low and stepping up share buybacks, even as RBC trims its 2026 profit outlook. Lower costs
Greg Abel's Berkshire shifts from hoarding cash to buying stocks and Alphabet
In his second quarter as CEO, Greg Abel reversed Warren Buffett's cautious stance, spending billions on buybacks and Alphabet. Berkshire's c
AIG's new CEO prioritizes growth over buybacks, RBC says
AIG shares fell after its Q2 update, with RBC noting the new CEO prefers using excess capital for growth and deals rather than buybacks. Inv
RBC trims Albemarle target to $157, sees lithium demand intact
RBC Capital Markets trimmed its price target on Albemarle to $157 from $166, citing cooler lithium prices in the second quarter. Still, the